Clinical Role - Specialty Pharmacy
Pharmacy Times® is a leader in providing expert insights and clinical updates to specialty pharmacists and reaches more than 200,000 pharmacy professionals in total.
Panel discusses the importance of patient education regarding toxicities as well as different treatment regimens for chronic lymphocytic leukemia.
Study shows that an individual's response to immunotherapy can be predicted within weeks, based on increasing or decreasing levels of circulating tumor DNA.
Jacob Kettle, PharmD, BCOP, and Allison Butts, PharmD, BCOP, discuss the role of biosimilars in the management of breast cancer.
By using a non-invasive screening model, care providers can help catch and treat more cases of colorectal cancer, a new study suggests.
Study examines the effect of a low-calorie, plant-based diet combined with vitamin C in helping to kill cancer cells.
Cancer care providers have increasingly been using biosimilars on a case-by-case basis with patients.
FDA Approves Belantamab Mafodotin-blmf for Treatment of Patients with Relapsed, Refractory Multiple Myeloma
Belantamab mafodotin-blmf is the first anti-BCMA therapy approved by the FDA for the treatment of patients with relapsed or refractory multiple myeloma who received at least 4 prior therapies.
Introducing an online PharmD program presents a unique set of challenges for educators.
JD Power 2020 US Pharmacy Study ranks Good Neighbor Pharmacy highest among brick-and-mortar chain drug store pharmacies in customer satisfaction.
A review of the potential agents or regimens that Allison Butts, PharmD, BCOP, is looking forward to seeing transition from metastatic management to the early stage setting.
A recent study evaluated the efficacy of venetoclax monotherapy in participants with relapsed or refractory chronic lymphocytic leukemia.
Women comprise more than 60% of pharmacy graduates, yet gender gaps still exist in pharmacy ownership, school deanships, and other leadership positions.